Prognostic impact of tumor-infiltrating lymphocytes and neutrophils in resected non-small cell lung carcinoma
The prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized method for counting TILs. In this report, we applied the method proposed by the International Immuno-Oncology Biomarkers Working Group for the assess...
Saved in:
| Published in: | Human pathology Vol. 125; pp. 87 - 96 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
01-07-2022
Elsevier Limited |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized method for counting TILs. In this report, we applied the method proposed by the International Immuno-Oncology Biomarkers Working Group for the assessment of TILs to count the number of tumor-infiltrating neutrophils (TINs). We then analyzed the association between TIL counts, TIN counts, and clinicopathological factors in lung cancer. We retrospectively analyzed a series of 1191 Japanese patients with resected lung adenocarcinoma and squamous cell carcinoma, which were restaged according to the eighth edition of the TNM staging system. Tumors were classified according to the 2015 WHO classification of lung carcinoma. Recurrence-free probability (RFP) and overall survival (OS) were analyzed using the log-rank test and Cox proportional hazard model. Using multivariate analysis for patient outcome in patients with adenocarcinoma, high TIN counts were an independent prognostic factor for worse RFP (hazard ratio [HR]: 1.94, p < 0.001) and worse OS (hazard ratio [HR]: 1.75, p = 0.006). On the other hand, TIL counts were not related to patient outcome. We have demonstrated that high TINs are unfavorable prognostic markers for resected lung adenocarcinoma. In resected lung squamous cell carcinoma, TIL and TIN counts were not related to patient prognosis. It has been suggested that the immune response to cancer cells may differ depending on the histological type. An understanding of how neutrophils are programmed to perform protumor activities is necessary for the future design of targeted immunotherapies. |
|---|---|
| AbstractList | The prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized method for counting TILs. In this report, we applied the method proposed by the International Immuno-Oncology Biomarkers Working Group for the assessment of TILs to count the number of tumor-infiltrating neutrophils (TINs). We then analyzed the association between TIL counts, TIN counts, and clinicopathological factors in lung cancer. We retrospectively analyzed a series of 1191 Japanese patients with resected lung adenocarcinoma and squamous cell carcinoma, which were restaged according to the eighth edition of the TNM staging system. Tumors were classified according to the 2015 WHO classification of lung carcinoma. Recurrence-free probability (RFP) and overall survival (OS) were analyzed using the log-rank test and Cox proportional hazard model. Using multivariate analysis for patient outcome in patients with adenocarcinoma, high TIN counts were an independent prognostic factor for worse RFP (hazard ratio [HR]: 1.94, p < 0.001) and worse OS (hazard ratio [HR]: 1.75, p = 0.006). On the other hand, TIL counts were not related to patient outcome. We have demonstrated that high TINs are unfavorable prognostic markers for resected lung adenocarcinoma. In resected lung squamous cell carcinoma, TIL and TIN counts were not related to patient prognosis. It has been suggested that the immune response to cancer cells may differ depending on the histological type. An understanding of how neutrophils are programmed to perform protumor activities is necessary for the future design of targeted immunotherapies. SummaryThe prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized method for counting TILs. In this report, we applied the method proposed by the International Immuno-Oncology Biomarkers Working Group for the assessment of TILs to count the number of tumor-infiltrating neutrophils (TINs). We then analyzed the association between TIL counts, TIN counts, and clinicopathological factors in lung cancer. We retrospectively analyzed a series of 1191 Japanese patients with resected lung adenocarcinoma and squamous cell carcinoma, which were restaged according to the eighth edition of the TNM staging system. Tumors were classified according to the 2015 WHO classification of lung carcinoma. Recurrence-free probability (RFP) and overall survival (OS) were analyzed using the log-rank test and Cox proportional hazard model. Using multivariate analysis for patient outcome in patients with adenocarcinoma, high TIN counts were an independent prognostic factor for worse RFP (hazard ratio [HR]: 1.94, p < 0.001) and worse OS (hazard ratio [HR]: 1.75, p = 0.006). On the other hand, TIL counts were not related to patient outcome. We have demonstrated that high TINs are unfavorable prognostic markers for resected lung adenocarcinoma. In resected lung squamous cell carcinoma, TIL and TIN counts were not related to patient prognosis. It has been suggested that the immune response to cancer cells may differ depending on the histological type. An understanding of how neutrophils are programmed to perform protumor activities is necessary for the future design of targeted immunotherapies. The prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized method for counting TILs. In this report, we applied the method proposed by the International Immuno-Oncology Biomarkers Working Group for the assessment of TILs to count the number of tumor-infiltrating neutrophils (TINs). We then analyzed the association between TIL counts, TIN counts, and clinicopathological factors in lung cancer. We retrospectively analyzed a series of 1191 Japanese patients with resected lung adenocarcinoma and squamous cell carcinoma, which were restaged according to the eighth edition of the TNM staging system. Tumors were classified according to the 2015 WHO classification of lung carcinoma. Recurrence-free probability (RFP) and overall survival (OS) were analyzed using the log-rank test and Cox proportional hazard model. Using multivariate analysis for patient outcome in patients with adenocarcinoma, high TIN counts were an independent prognostic factor for worse RFP (hazard ratio [HR]: 1.94, p < 0.001) and worse OS (hazard ratio [HR]: 1.75, p = 0.006). On the other hand, TIL counts were not related to patient outcome. We have demonstrated that high TINs are unfavorable prognostic markers for resected lung adenocarcinoma. In resected lung squamous cell carcinoma, TIL and TIN counts were not related to patient prognosis. It has been suggested that the immune response to cancer cells may differ depending on the histological type. An understanding of how neutrophils are programmed to perform protumor activities is necessary for the future design of targeted immunotherapies.The prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized method for counting TILs. In this report, we applied the method proposed by the International Immuno-Oncology Biomarkers Working Group for the assessment of TILs to count the number of tumor-infiltrating neutrophils (TINs). We then analyzed the association between TIL counts, TIN counts, and clinicopathological factors in lung cancer. We retrospectively analyzed a series of 1191 Japanese patients with resected lung adenocarcinoma and squamous cell carcinoma, which were restaged according to the eighth edition of the TNM staging system. Tumors were classified according to the 2015 WHO classification of lung carcinoma. Recurrence-free probability (RFP) and overall survival (OS) were analyzed using the log-rank test and Cox proportional hazard model. Using multivariate analysis for patient outcome in patients with adenocarcinoma, high TIN counts were an independent prognostic factor for worse RFP (hazard ratio [HR]: 1.94, p < 0.001) and worse OS (hazard ratio [HR]: 1.75, p = 0.006). On the other hand, TIL counts were not related to patient outcome. We have demonstrated that high TINs are unfavorable prognostic markers for resected lung adenocarcinoma. In resected lung squamous cell carcinoma, TIL and TIN counts were not related to patient prognosis. It has been suggested that the immune response to cancer cells may differ depending on the histological type. An understanding of how neutrophils are programmed to perform protumor activities is necessary for the future design of targeted immunotherapies. |
| Author | Ibuki, Emi Haba, Reiji Kadota, Kyuichi Yoshida, Chihiro Ishikawa, Ryou Kimura, Nachino Go, Tetsuhiko Ikeda, Toshihiro Yokomise, Hiroyasu |
| Author_xml | – sequence: 1 givenname: Ryou orcidid: 0000-0001-5625-3259 surname: Ishikawa fullname: Ishikawa, Ryou organization: Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan – sequence: 2 givenname: Kyuichi surname: Kadota fullname: Kadota, Kyuichi email: kadotak@med.shimane-u.ac.jp organization: Department of Pathology, Faculty of Medicine, Shimane University, 89-1, Ennya-cho, Izumo-shi, Shimane 693-8501, Japan – sequence: 3 givenname: Toshihiro surname: Ikeda fullname: Ikeda, Toshihiro organization: Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan – sequence: 4 givenname: Chihiro surname: Yoshida fullname: Yoshida, Chihiro organization: Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan – sequence: 5 givenname: Nachino surname: Kimura fullname: Kimura, Nachino organization: Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan – sequence: 6 givenname: Emi surname: Ibuki fullname: Ibuki, Emi organization: Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan – sequence: 7 givenname: Tetsuhiko surname: Go fullname: Go, Tetsuhiko organization: Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan – sequence: 8 givenname: Hiroyasu surname: Yokomise fullname: Yokomise, Hiroyasu organization: Department of General Thoracic Surgery, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan – sequence: 9 givenname: Reiji surname: Haba fullname: Haba, Reiji organization: Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kagawa 761-0793, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35483621$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU-LFDEQxYOsuLOrH0EJePHSbf52JyeRRV1hQQ96Dul09U6G7qRN0sJ8ezPM6MHL1iEF4fdeFfVu0FWIARB6TUlLCe3eH9r9tqy27FtGGGuJaAllz9COSs4axTW7QjtCRNco2vfX6CbnAyGUSiFfoGsuheIdozu0fE_xMcRcvMO--rmC44TLtsTU-DD5uSRbfHjE83FZ99EdC2Rsw4gDbCXFde_njH3ACTK4AvU_hiYvdp6xg_rMW9U6m5wPcbEv0fPJzhleXfot-vn504-7--bh25evdx8fGsd7URoGQvScdmoctJYDkQNnapQgFfSTAzUxpZ0gjhLNgdkR9GBrcTpOkglh-S16d_ZdU_y1QS5m8fm0jw0Qt2xYJxVjWve0om__Qw9xS6FuV6mea6WIEpWSZ8qlmHOCyazJLzYdDSXmlIc5mEse5pSHIcLUPKruzcV9GxYY_6n-BlCBD2cA6jl-e0gmOw_BwehTPagZo39ixB83SKJm |
| CitedBy_id | crossref_primary_10_1136_jitc_2022_005798 crossref_primary_10_1016_j_acra_2024_01_033 crossref_primary_10_1186_s12885_024_12074_3 |
| Cites_doi | 10.1016/j.jss.2009.08.029 10.1158/1078-0432.CCR-10-2805 10.1016/j.ccr.2009.06.017 10.1097/MPA.0000000000000914 10.1016/j.radonc.2017.12.030 10.1016/j.cllc.2018.04.008 10.1097/PAS.0000000000001323 10.1158/1078-0432.CCR-18-2544 10.1016/j.cellimm.2018.01.013 10.1164/rccm.201409-1671PP 10.1371/journal.pone.0224430 10.1093/annonc/mdu450 10.1002/cncr.26456 10.1016/j.jtcvs.2008.05.046 10.1097/PAP.0000000000000162 10.1016/j.jss.2011.03.068 10.1002/jso.25091 10.1159/000438523 10.1097/PAS.0000000000001409 10.1097/PAP.0000000000000161 10.1016/j.lungcan.2013.03.003 10.1111/his.13695 10.1016/j.ejca.2009.01.023 10.1101/gad.314617.118 10.1158/1078-0432.CCR-18-2013 |
| ContentType | Journal Article |
| Copyright | 2022 Copyright © 2022. Published by Elsevier Inc. Copyright Elsevier Limited Jul 2022 |
| Copyright_xml | – notice: 2022 – notice: Copyright © 2022. Published by Elsevier Inc. – notice: Copyright Elsevier Limited Jul 2022 |
| DBID | NPM AAYXX CITATION K9. 7X8 |
| DOI | 10.1016/j.humpath.2022.04.012 |
| DatabaseName | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-8392 |
| EndPage | 96 |
| ExternalDocumentID | 10_1016_j_humpath_2022_04_012 35483621 S0046817722001022 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: JSPS grantid: JP20K07392 funderid: https://doi.org/10.13039/501100001691 |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1CY 1P~ 1RT 1~. 1~5 3O- 3V. 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 7X7 8FI 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAXUO ABBQC ABFNM ABFRF ABJNI ABLJU ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFRT ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKRA AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AHMBA AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN AZQEC BENPR BKOJK BLXMC BNPGV BPHCQ BVXVI CAG COF DU5 EBS EFJIC EFLBG EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GUQSH HDY HMK HMO HVGLF HZ~ IH2 IHE J1W J5H K-O KOM L7B LCYCR M1P M29 M2O M41 MO0 N9A O-L O9- OAUVE OG0 OS0 OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- RIG ROL RPZ SAE SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSZ SV3 T5K UGJ UHS UNMZH UV1 WUQ X7M Z5R ZA5 ZGI ~G- AAQOH AAXKI AFJKZ AKRWK NPM AAYXX CITATION K9. 7X8 |
| ID | FETCH-LOGICAL-c374t-2e4473168db995b05b328d5e58e7fce8f289c40c1093e2ade9baaaa31df5244a3 |
| ISSN | 0046-8177 1532-8392 |
| IngestDate | Sat Oct 26 04:11:26 EDT 2024 Thu Oct 10 17:22:44 EDT 2024 Thu Sep 26 17:24:13 EDT 2024 Wed Oct 16 00:40:42 EDT 2024 Fri Feb 23 02:40:24 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Prognosis Neutrophil Tumor-infiltrating lymphocytes Lung cancer |
| Language | English |
| License | Copyright © 2022. Published by Elsevier Inc. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c374t-2e4473168db995b05b328d5e58e7fce8f289c40c1093e2ade9baaaa31df5244a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-5625-3259 |
| PMID | 35483621 |
| PQID | 2673988084 |
| PQPubID | 105547 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_2658229971 proquest_journals_2673988084 crossref_primary_10_1016_j_humpath_2022_04_012 pubmed_primary_35483621 elsevier_sciencedirect_doi_10_1016_j_humpath_2022_04_012 |
| PublicationCentury | 2000 |
| PublicationDate | July 2022 2022-Jul 2022-07-00 20220701 |
| PublicationDateYYYYMMDD | 2022-07-01 |
| PublicationDate_xml | – month: 07 year: 2022 text: July 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Philadelphia |
| PublicationTitle | Human pathology |
| PublicationTitleAlternate | Hum Pathol |
| PublicationYear | 2022 |
| Publisher | Elsevier Inc Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
| References | (bib15) 2019 Teramukai, Kitano, Kishida (bib18) 2009; 45 Chen, Li, Liu (bib11) 2020; 15 Suzuki, Lin, Wei (bib24) 2018; 126 Nejati, Goldstein, Halperin (bib3) 2017; 46 Remark, Becker, Gomez (bib19) 2015; 191 Corredor, Wang, Zhou (bib30) 2019; 25 Ilie, Hofman, Ortholan (bib20) 2012; 118 Sideras, Galjart, Vasaturo (bib6) 2018; 118 Kilic, Landreneau, Luketich, Pennathur, Schuchert (bib8) 2011; 167 (bib28) 2015 Geng, Shao, He (bib10) 2015; 37 Kim, Lee, Ahn (bib9) 2019; 14 Horne, Jack, Gray (bib7) 2011; 171 Badalamenti, Fanale, Incorvaia (bib4) 2019; 343 Islami, Torre, Jemal (bib1) 2015; 4 Gonzalez, Hagerling, Werb (bib26) 2018; 32 Heikkinen, Bello, Wahab (bib16) 2019; 43 Hendry, Salgado, Gevaert (bib12) 2017; 24 (bib27) 2018 Wang, Chen, Yang (bib22) 2019; 25 Althobiti, Aleskandarany, Joseph (bib5) 2018; 73 Salgado, Denkert, Demaria (bib13) 2015; 26 Fuchs, Sioson, Sheen (bib17) 2020; 44 Carus, Ladekarl, Hager, Pilegaard, Nielsen, Donskov (bib21) 2013; 81 Fridlender, Sun, Kim (bib29) 2009; 16 Zer, Sung, Walia (bib23) 2018; 19 Sarraf, Belcher, Raevsky, Nicholson, Goldstraw, Lim (bib25) 2009; 137 Hendry, Salgado, Gevaert (bib14) 2017; 24 Suzuki, Kachala, Kadota (bib2) 2011; 17 Heikkinen (10.1016/j.humpath.2022.04.012_bib16) 2019; 43 Fridlender (10.1016/j.humpath.2022.04.012_bib29) 2009; 16 Sarraf (10.1016/j.humpath.2022.04.012_bib25) 2009; 137 Kim (10.1016/j.humpath.2022.04.012_bib9) 2019; 14 Hendry (10.1016/j.humpath.2022.04.012_bib14) 2017; 24 (10.1016/j.humpath.2022.04.012_bib28) 2015 Fuchs (10.1016/j.humpath.2022.04.012_bib17) 2020; 44 Kilic (10.1016/j.humpath.2022.04.012_bib8) 2011; 167 Gonzalez (10.1016/j.humpath.2022.04.012_bib26) 2018; 32 Suzuki (10.1016/j.humpath.2022.04.012_bib24) 2018; 126 Corredor (10.1016/j.humpath.2022.04.012_bib30) 2019; 25 Suzuki (10.1016/j.humpath.2022.04.012_bib2) 2011; 17 Islami (10.1016/j.humpath.2022.04.012_bib1) 2015; 4 (10.1016/j.humpath.2022.04.012_bib15) 2019 Geng (10.1016/j.humpath.2022.04.012_bib10) 2015; 37 Sideras (10.1016/j.humpath.2022.04.012_bib6) 2018; 118 Remark (10.1016/j.humpath.2022.04.012_bib19) 2015; 191 (10.1016/j.humpath.2022.04.012_bib27) 2018 Horne (10.1016/j.humpath.2022.04.012_bib7) 2011; 171 Wang (10.1016/j.humpath.2022.04.012_bib22) 2019; 25 Hendry (10.1016/j.humpath.2022.04.012_bib12) 2017; 24 Althobiti (10.1016/j.humpath.2022.04.012_bib5) 2018; 73 Chen (10.1016/j.humpath.2022.04.012_bib11) 2020; 15 Carus (10.1016/j.humpath.2022.04.012_bib21) 2013; 81 Salgado (10.1016/j.humpath.2022.04.012_bib13) 2015; 26 Ilie (10.1016/j.humpath.2022.04.012_bib20) 2012; 118 Teramukai (10.1016/j.humpath.2022.04.012_bib18) 2009; 45 Nejati (10.1016/j.humpath.2022.04.012_bib3) 2017; 46 Zer (10.1016/j.humpath.2022.04.012_bib23) 2018; 19 Badalamenti (10.1016/j.humpath.2022.04.012_bib4) 2019; 343 |
| References_xml | – volume: 191 start-page: 377 year: 2015 end-page: 390 ident: bib19 article-title: The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome publication-title: Am J Respir Crit Care Med contributor: fullname: Gomez – volume: 19 start-page: 426 year: 2018 end-page: 434 ident: bib23 article-title: Correlation of neutrophil to lymphocyte ratio and absolute neutrophil count with outcomes with PD-1 Axis inhibitors in patients with advanced non-small-cell lung cancer publication-title: Clin Lung Cancer contributor: fullname: Walia – volume: 32 start-page: 1267 year: 2018 end-page: 1284 ident: bib26 article-title: Roles of the immune system in cancer: from tumor initiation to metastatic progression publication-title: Genes Dev contributor: fullname: Werb – volume: 24 start-page: 311 year: 2017 end-page: 335 ident: bib14 article-title: Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno-oncology Biomarkers working group: Part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors publication-title: Adv Anat Pathol contributor: fullname: Gevaert – volume: 118 start-page: 68 year: 2018 end-page: 76 ident: bib6 article-title: Prognostic value of intra-tumoral CD8(+)/FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis publication-title: J Surg Oncol contributor: fullname: Vasaturo – volume: 25 start-page: 1957 year: 2019 end-page: 1969 ident: bib22 article-title: Tumor-contacted neutrophils promote metastasis by a CD90-TIMP-1 juxtacrine-paracrine loop publication-title: Clin Cancer Res Off J Am Assoc Cancer Res contributor: fullname: Yang – volume: 126 start-page: 499 year: 2018 end-page: 505 ident: bib24 article-title: Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer publication-title: Radiother Oncol J Eur Soc Therap Radiol Oncol contributor: fullname: Wei – volume: 343 start-page: 103753 year: 2019 ident: bib4 article-title: Role of tumor-infiltrating lymphocytes in patients with solid tumors: can a drop dig a stone? publication-title: Cell Immunol contributor: fullname: Incorvaia – volume: 167 start-page: 207 year: 2011 end-page: 210 ident: bib8 article-title: Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors publication-title: J Surg Res contributor: fullname: Schuchert – volume: 14 year: 2019 ident: bib9 article-title: The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma publication-title: PLoS One contributor: fullname: Ahn – year: 2015 ident: bib28 publication-title: WHO classification of tumors of the lung, pleura, thymus and heart – volume: 73 start-page: 887 year: 2018 end-page: 896 ident: bib5 article-title: Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance publication-title: Histopathology contributor: fullname: Joseph – year: 2019 ident: bib15 article-title: International agency for research on C. Breast tumours – volume: 118 start-page: 1726 year: 2012 end-page: 1737 ident: bib20 article-title: Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer publication-title: Cancer contributor: fullname: Ortholan – volume: 37 start-page: 1560 year: 2015 end-page: 1571 ident: bib10 article-title: Prognostic role of tumor-infiltrating lymphocytes in lung cancer: a meta-analysis publication-title: Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol contributor: fullname: He – volume: 44 start-page: 536 year: 2020 end-page: 544 ident: bib17 article-title: Assessment of tumor-infiltrating lymphocytes using international TILs working group (ITWG) system is a strong predictor of overall survival in colorectal carcinoma: a study of 1034 patients publication-title: Am J Surg Pathol contributor: fullname: Sheen – volume: 171 start-page: 1 year: 2011 end-page: 5 ident: bib7 article-title: Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer publication-title: J Surg Res contributor: fullname: Gray – volume: 81 start-page: 130 year: 2013 end-page: 137 ident: bib21 article-title: Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome publication-title: Lung Cancer contributor: fullname: Donskov – volume: 17 start-page: 5247 year: 2011 end-page: 5256 ident: bib2 article-title: Prognostic immune markers in non-small cell lung cancer publication-title: Clin Cancer Res J Am Assoc Cancer Res contributor: fullname: Kadota – volume: 16 start-page: 183 year: 2009 end-page: 194 ident: bib29 article-title: Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN publication-title: Cancer Cell contributor: fullname: Kim – volume: 43 start-page: 1392 year: 2019 end-page: 1396 ident: bib16 article-title: Assessment of tumor-infiltrating lymphocytes predicts the behavior of early-stage oral tongue cancer publication-title: Am J Surg Pathol contributor: fullname: Wahab – volume: 15 year: 2020 ident: bib11 article-title: Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: a meta-analysis publication-title: PLoS One contributor: fullname: Liu – volume: 45 start-page: 1950 year: 2009 end-page: 1958 ident: bib18 article-title: Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03 publication-title: Eur J Cancer contributor: fullname: Kishida – volume: 137 start-page: 425 year: 2009 end-page: 428 ident: bib25 article-title: Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer publication-title: J Thorac Cardiovasc Surg contributor: fullname: Lim – volume: 4 start-page: 327 year: 2015 end-page: 338 ident: bib1 article-title: Global trends of lung cancer mortality and smoking prevalence publication-title: Transl Lung Cancer Res contributor: fullname: Jemal – year: 2018 ident: bib27 publication-title: 8th edition of the American Joint Committee on cancer TNM staging manual – volume: 46 start-page: 1180 year: 2017 end-page: 1187 ident: bib3 article-title: Prognostic significance of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemotherapy publication-title: Pancreas contributor: fullname: Halperin – volume: 25 start-page: 1526 year: 2019 end-page: 1534 ident: bib30 article-title: Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer publication-title: Clin Cancer Res Off J Am Assoc Cancer Res contributor: fullname: Zhou – volume: 26 start-page: 259 year: 2015 end-page: 271 ident: bib13 article-title: The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 publication-title: Ann Oncol Off J Eur Soc Med Oncol contributor: fullname: Demaria – volume: 24 start-page: 235 year: 2017 end-page: 251 ident: bib12 article-title: Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology Biomarkers working group: Part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research publication-title: Adv Anat Pathol contributor: fullname: Gevaert – volume: 167 start-page: 207 year: 2011 ident: 10.1016/j.humpath.2022.04.012_bib8 article-title: Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors publication-title: J Surg Res doi: 10.1016/j.jss.2009.08.029 contributor: fullname: Kilic – volume: 17 start-page: 5247 year: 2011 ident: 10.1016/j.humpath.2022.04.012_bib2 article-title: Prognostic immune markers in non-small cell lung cancer publication-title: Clin Cancer Res J Am Assoc Cancer Res doi: 10.1158/1078-0432.CCR-10-2805 contributor: fullname: Suzuki – volume: 4 start-page: 327 year: 2015 ident: 10.1016/j.humpath.2022.04.012_bib1 article-title: Global trends of lung cancer mortality and smoking prevalence publication-title: Transl Lung Cancer Res contributor: fullname: Islami – volume: 16 start-page: 183 year: 2009 ident: 10.1016/j.humpath.2022.04.012_bib29 article-title: Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.06.017 contributor: fullname: Fridlender – volume: 46 start-page: 1180 year: 2017 ident: 10.1016/j.humpath.2022.04.012_bib3 article-title: Prognostic significance of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemotherapy publication-title: Pancreas doi: 10.1097/MPA.0000000000000914 contributor: fullname: Nejati – volume: 126 start-page: 499 year: 2018 ident: 10.1016/j.humpath.2022.04.012_bib24 article-title: Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer publication-title: Radiother Oncol J Eur Soc Therap Radiol Oncol doi: 10.1016/j.radonc.2017.12.030 contributor: fullname: Suzuki – volume: 19 start-page: 426 year: 2018 ident: 10.1016/j.humpath.2022.04.012_bib23 article-title: Correlation of neutrophil to lymphocyte ratio and absolute neutrophil count with outcomes with PD-1 Axis inhibitors in patients with advanced non-small-cell lung cancer publication-title: Clin Lung Cancer doi: 10.1016/j.cllc.2018.04.008 contributor: fullname: Zer – year: 2018 ident: 10.1016/j.humpath.2022.04.012_bib27 – volume: 43 start-page: 1392 year: 2019 ident: 10.1016/j.humpath.2022.04.012_bib16 article-title: Assessment of tumor-infiltrating lymphocytes predicts the behavior of early-stage oral tongue cancer publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000001323 contributor: fullname: Heikkinen – volume: 25 start-page: 1957 year: 2019 ident: 10.1016/j.humpath.2022.04.012_bib22 article-title: Tumor-contacted neutrophils promote metastasis by a CD90-TIMP-1 juxtacrine-paracrine loop publication-title: Clin Cancer Res Off J Am Assoc Cancer Res doi: 10.1158/1078-0432.CCR-18-2544 contributor: fullname: Wang – volume: 343 start-page: 103753 year: 2019 ident: 10.1016/j.humpath.2022.04.012_bib4 article-title: Role of tumor-infiltrating lymphocytes in patients with solid tumors: can a drop dig a stone? publication-title: Cell Immunol doi: 10.1016/j.cellimm.2018.01.013 contributor: fullname: Badalamenti – volume: 191 start-page: 377 year: 2015 ident: 10.1016/j.humpath.2022.04.012_bib19 article-title: The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201409-1671PP contributor: fullname: Remark – volume: 14 year: 2019 ident: 10.1016/j.humpath.2022.04.012_bib9 article-title: The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma publication-title: PLoS One doi: 10.1371/journal.pone.0224430 contributor: fullname: Kim – volume: 26 start-page: 259 year: 2015 ident: 10.1016/j.humpath.2022.04.012_bib13 article-title: The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 publication-title: Ann Oncol Off J Eur Soc Med Oncol doi: 10.1093/annonc/mdu450 contributor: fullname: Salgado – volume: 118 start-page: 1726 year: 2012 ident: 10.1016/j.humpath.2022.04.012_bib20 article-title: Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer publication-title: Cancer doi: 10.1002/cncr.26456 contributor: fullname: Ilie – volume: 137 start-page: 425 year: 2009 ident: 10.1016/j.humpath.2022.04.012_bib25 article-title: Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2008.05.046 contributor: fullname: Sarraf – year: 2015 ident: 10.1016/j.humpath.2022.04.012_bib28 – volume: 24 start-page: 235 year: 2017 ident: 10.1016/j.humpath.2022.04.012_bib12 publication-title: Adv Anat Pathol doi: 10.1097/PAP.0000000000000162 contributor: fullname: Hendry – year: 2019 ident: 10.1016/j.humpath.2022.04.012_bib15 – volume: 171 start-page: 1 year: 2011 ident: 10.1016/j.humpath.2022.04.012_bib7 article-title: Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer publication-title: J Surg Res doi: 10.1016/j.jss.2011.03.068 contributor: fullname: Horne – volume: 15 year: 2020 ident: 10.1016/j.humpath.2022.04.012_bib11 article-title: Prognostic value of the common tumour-infiltrating lymphocyte subtypes for patients with non-small cell lung cancer: a meta-analysis publication-title: PLoS One contributor: fullname: Chen – volume: 118 start-page: 68 year: 2018 ident: 10.1016/j.humpath.2022.04.012_bib6 article-title: Prognostic value of intra-tumoral CD8(+)/FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis publication-title: J Surg Oncol doi: 10.1002/jso.25091 contributor: fullname: Sideras – volume: 37 start-page: 1560 year: 2015 ident: 10.1016/j.humpath.2022.04.012_bib10 article-title: Prognostic role of tumor-infiltrating lymphocytes in lung cancer: a meta-analysis publication-title: Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol doi: 10.1159/000438523 contributor: fullname: Geng – volume: 44 start-page: 536 year: 2020 ident: 10.1016/j.humpath.2022.04.012_bib17 article-title: Assessment of tumor-infiltrating lymphocytes using international TILs working group (ITWG) system is a strong predictor of overall survival in colorectal carcinoma: a study of 1034 patients publication-title: Am J Surg Pathol doi: 10.1097/PAS.0000000000001409 contributor: fullname: Fuchs – volume: 24 start-page: 311 year: 2017 ident: 10.1016/j.humpath.2022.04.012_bib14 publication-title: Adv Anat Pathol doi: 10.1097/PAP.0000000000000161 contributor: fullname: Hendry – volume: 81 start-page: 130 year: 2013 ident: 10.1016/j.humpath.2022.04.012_bib21 article-title: Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome publication-title: Lung Cancer doi: 10.1016/j.lungcan.2013.03.003 contributor: fullname: Carus – volume: 73 start-page: 887 year: 2018 ident: 10.1016/j.humpath.2022.04.012_bib5 article-title: Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance publication-title: Histopathology doi: 10.1111/his.13695 contributor: fullname: Althobiti – volume: 45 start-page: 1950 year: 2009 ident: 10.1016/j.humpath.2022.04.012_bib18 article-title: Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2009.01.023 contributor: fullname: Teramukai – volume: 32 start-page: 1267 year: 2018 ident: 10.1016/j.humpath.2022.04.012_bib26 article-title: Roles of the immune system in cancer: from tumor initiation to metastatic progression publication-title: Genes Dev doi: 10.1101/gad.314617.118 contributor: fullname: Gonzalez – volume: 25 start-page: 1526 year: 2019 ident: 10.1016/j.humpath.2022.04.012_bib30 article-title: Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer publication-title: Clin Cancer Res Off J Am Assoc Cancer Res doi: 10.1158/1078-0432.CCR-18-2013 contributor: fullname: Corredor |
| SSID | ssj0011545 |
| Score | 2.4442596 |
| Snippet | The prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized method... SummaryThe prognostic impact of tumor-infiltrating lymphocytes (TILs) has been determined in non-small cell lung carcinoma; however, there is no standardized... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 87 |
| SubjectTerms | Abscesses Biomarkers Clinical outcomes Immunotherapy Lung cancer Lymphocytes Medical prognosis Neutrophil Neutrophils Patients Prognosis Tumor-infiltrating lymphocytes Tumors Working groups |
| Title | Prognostic impact of tumor-infiltrating lymphocytes and neutrophils in resected non-small cell lung carcinoma |
| URI | https://dx.doi.org/10.1016/j.humpath.2022.04.012 https://www.ncbi.nlm.nih.gov/pubmed/35483621 https://www.proquest.com/docview/2673988084 https://www.proquest.com/docview/2658229971 |
| Volume | 125 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6ISFeEN-UDWQk3qaUxLGb5BGNIngAIVYkxEvk2A7N1iZT0wj1v99d7CStxsSHRB-iys6Hdffz-Xy-D0JemTDItVSZl2jlezybck_mQnuZYb6Op4GReVvE9iz69C1-O-Oz0airazC0_VdOQxvwGiNn_4Lb_UuhAf4Dz-EKXIfrH_H987pC3znMwzpEQG6aVbX24PXFsk2TW_44WW6Bj5Xaot0VjeelaTbr6nJRLGsb41KDKETfgKr06hUeYKON_2TZYJAuFiAqKyfSnWprjwOwwvGepf5DvSgu5E-ro26rppfwEvbDNh5t2xRqUfQPXBjdts8reHRRrKtBMkGD7Tvd6XE2Czb4tzpDWhdMs-friVt1Lw5cVRfTyWMQ2GGyL7CZ2BG5br22i7etjnttWbAWivPJAqYIkGGCY2oz3DoX7v2M22c4EhwIYzbl3gG5xUCOoRj9Lr70h1SofVoHBjvuIUDs9S8_dZPqc9PWplVx5vfIXbc3oW8sqO6TkSkfkNsfnffFQ7IasEUttmiV0-vYojvYooAtuoMtWpS0wxbtsUURWxSxRXtsPSJf383mp-89V67DU2HENx4znLd10HSWJCLzRRayWAsjYhPlysQ57O0V9xUmMDNMapNkEn5hoHMBSqYMH5ND-K55SijPpzKRTCW-FJxpE6swz4JIZ8pgRstoTCYdJdNLm5Ul7dwVz1NH-hRJn_o8BdKPSdzRO3WqpVUZU4DI7x497viTunlep2wahQksfTEfk5d9N0hmJJcsTdXgPQKrKSRRMCZPLF_7wYaCx6A6Bs_-fVxH5M4wtY7J4WbdmOfkoNbNixamV56-w3o |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+impact+of+tumor-infiltrating+lymphocytes+and+neutrophils+in+resected+non-small+cell+lung+carcinoma&rft.jtitle=Human+pathology&rft.au=Ishikawa%2C+Ryou&rft.au=Kadota%2C+Kyuichi&rft.au=Ikeda%2C+Toshihiro&rft.au=Yoshida%2C+Chihiro&rft.date=2022-07-01&rft.pub=Elsevier+Inc&rft.issn=0046-8177&rft.eissn=1532-8392&rft.volume=125&rft.spage=87&rft.epage=96&rft_id=info:doi/10.1016%2Fj.humpath.2022.04.012&rft.externalDocID=S0046817722001022 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0046-8177&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0046-8177&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0046-8177&client=summon |